Apoptosis

Apoptosis is a term derived from the Greek for “the falling of leaves from a tree” and refers to the programmed cell death process by which an organism’s own autonomous mechanisms eliminate aged, damaged, or unwanted cells in an energy-dependent manner without leaving traces. It was first defined as “programmed cell death” in 1964 and the term “apoptosis” was introduced into the literature in 1972 by Kerr and colleagues. Kerr observed condensed chromatin fragments within the nuclei of cells during this process and noted the preservation of organelles, leading him to name it “shrinkage necrosis.” Apoptosis plays a critical role in normal development and the maintenance of tissue homeostasis in multicellular organisms. Unlike necrosis, apoptosis is a controlled, non-inflammatory process that typically affects individual cells.

Apoptosis is characterized by distinct morphological changes. In the early phase, cells shrink, lose contact with neighboring cells, and lose approximately one-third of their volume. Blebbing and bubbling occur on the plasma membrane. Chromatin condenses, the nucleus assumes a horseshoe-shaped structure, and DNA is cleaved at internucleosomal regions to produce a “ladder pattern.” Normally, seven DNA breaks are repaired, but in apoptosis approximately 300,000 breaks occur and are irreparable. The cytoskeleton disintegrates, phosphatidylserine translocates from the inner to the outer leaflet of the plasma membrane, triggering recognition and phagocytosis by macrophages. Apoptotic bodies are rapidly cleared by macrophages or neighboring cells without cytokine release or inflammation. The process is typically completed within 30 to 60 minutes.

^{Frog, Caenorhabditis elegans and human apoptosis (}Source⁾

Apoptotic cell death occurs continuously in various tissues of the organism to maintain tissue homeostasis. It is estimated that approximately 1x10¹¹ cells undergo apoptosis daily; this is equivalent to the renewal of an adult human’s body weight every 18 to 24 months. Examples of such tissues include:

• Small Intestine: Cells generated at the base of crypts migrate toward the villi over 3 to 4 days and are shed into the intestinal lumen via apoptosis.
• Skin: Keratinocytes differentiate as they migrate from the basal layer to the stratum corneum and die by apoptosis to form a protective layer of dead cells.
• Thymus: Ineffective or autoreactive T lymphocytes are eliminated by apoptosis.
• Uterus: Endometrial cells are shed by apoptosis during menstruation.
• Brain: Certain neurons are removed by apoptosis during synapse formation.
• Apoptosis is also essential during development. For example, in Caenorhabditis elegans, 131 of 1090 cells are eliminated by apoptosis; during frog metamorphosis, tail cells disappear by apoptosis; and in the human embryo, interdigital webs are removed by apoptosis.

Apoptosis is a genetically regulated process controlled by three main components: Bcl-2 family proteins, caspases, and Apaf-1 protein. Apoptosis is induced through two major pathways: intrinsic and extrinsic:

• Intrinsic Pathway: Centered on mitochondria. Cellular stress (radiation, oxidative stress, growth factor deprivation) is detected by pro-apoptotic proteins (Bax, Bad). Bax forms pores in the mitochondrial membrane, leading to the release of molecules such as cytochrome c and Apoptosis-Inducing Factor (AIF) into the cytosol. Cytochrome c binds Apaf-1 and procaspase-9 to form the “apoptosome” complex, which activates caspase-9 and initiates the caspase cascade. Anti-apoptotic proteins (Bcl-2, Bcl-xL) inhibit this pore formation.
• Extrinsic Pathway: Death receptors on the cell surface (Fas/CD95, TNFR-1) interact with their ligands (FasL, TNF). This activates proteins such as FADD or TRADD, leading to the conversion of procaspase-8 into active caspase-8 and initiation of the caspase cascade.

Caspases (cysteine aspartate proteases) are the effector molecules of apoptosis. Procaspases are converted into active caspases that cleave cytoskeletal proteins (lamins, actin), DNA repair enzymes (PARP, DNA topoisomerase II), and CAD (caspase-activated DNase). CAD cleaves DNA into nucleosomal units. Caspase-independent proteins such as AIF and endonuclease G also translocate to the nucleus and contribute to DNA fragmentation.

Apoptosis is tightly linked to the cell cycle. The cell cycle consists of interphase (G1, S, G2) and mitosis (M). Cyclins and cyclin-dependent kinases (CDKs) regulate progression through the cycle. For example, the Cyclin D-CDK4 complex phosphorylates the retinoblastoma protein (RB), releasing E2F to enable transition into the S phase. Apoptosis is triggered in response to cell cycle abnormalities such as DNA damage. If DNA damage is detected at the G1/S or G2/M checkpoints, tumor suppressor genes such as p53 initiate apoptosis. p53 induces inhibitors such as p21 to halt the cycle or trigger apoptosis. The ubiquitin-proteasome pathway contributes to cell cycle regulation by mediating cyclin degradation.

• Apoptosis: A programmed, energy-dependent, non-inflammatory process. Cells shrink, chromatin condenses, DNA fragments, the membrane remains intact, and apoptotic bodies are phagocytosed.
• Necrosis: An uncontrolled, traumatic form of cell death. Cells swell, the membrane ruptures, chromatin remains normal, and inflammation is triggered.

Apoptosis can be detected by morphological and molecular methods:

• Morphological Methods: Light, fluorescence, electron, and phase-contrast microscopy are used to observe cell shrinkage, chromatin condensation, and apoptotic bodies.
• Immunohistochemical Methods: Annexin V (for phosphatidylserine detection), TUNEL (for DNA breaks), M30 (for keratin 18 cleavage), and caspase-3 antibodies are employed.
• Biochemical Methods: Agarose gel electrophoresis (DNA ladder pattern), Western blotting, flow cytometry.
• Immunological Methods: ELISA, fluorometric assays.
• Molecular Biology Methods: DNA microarrays.

Apoptosis plays a role in both physiological (cell renewal) and pathological processes. Disruption of its balance contributes to various diseases:

• Cancer: Reduced apoptosis and increased proliferation contribute to carcinogenesis. Chemotherapy induces apoptosis to eliminate tumor cells, but resistance to apoptosis leads to treatment failure.
• Neurodegenerative Diseases: Increased apoptosis contributes to neuronal loss in diseases such as Alzheimer’s.
• Autoimmune Diseases: Failure to eliminate autoreactive lymphocytes by apoptosis leads to disease.
• Viral Infections: Viruses (e.g., HPV, EBV) can suppress apoptosis, thereby increasing cancer risk.
• AIDS: Increased apoptosis results in loss of T lymphocytes.

Apoptosis is a target in the treatment of many diseases. In cancer therapy, the goal is to induce apoptosis (e.g., by activating p53 or stimulating death receptors); in neurodegenerative diseases, the aim is to inhibit apoptosis (e.g., using caspase inhibitors). Examples of therapeutic approaches include:

• Gene Therapy: Replacement of the p53 gene.
• Molecular Targeting: Growth factors, soluble FasL, Bcl-2 modulators.
• Pharmacological Molecules: Caspase activators (for cancer), caspase inhibitors (for ischemia and neurodegeneration).
• TNF receptor antagonists are approved for rheumatoid arthritis and Crohn’s disease. Nitric oxide (NO) can either induce or inhibit apoptosis depending on dose and cell type.

Apoptosis plays a critical role in development, homeostasis, and pathological processes. Elucidation of its molecular mechanisms has enabled novel therapeutic approaches for cancer, neurodegenerative diseases, autoimmune disorders, and infectious diseases. Apoptosis research also holds significant potential in regenerative medicine and biomedical engineering.